Cue Biopharma
63 hedge funds and large institutions have $168M invested in Cue Biopharma in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
18.98% more ownership
Funds ownership: 26.93% → 45.91% (+19%)
Holders
63
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$29.7M | |
| 2 | +$9.55M | |
| 3 | +$4.29M | |
| 4 |
PM
Precept Management
Dallas,
Texas
|
+$2.7M |
| 5 |
BlackRock
New York
|
+$2.64M |
Top Sellers
| 1 | -$591K | |
| 2 | -$422K | |
| 3 | -$164K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$135K |
| 5 |
Millennium Management
New York
|
-$117K |